Alaunos Therapeutics, Inc. Proceeds from Contributed Capital
Alaunos Therapeutics, Inc. (TCRT) reported Proceeds from Contributed Capital of $500.00 thousand for the 127-month period ending 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2014-05-08
- Alaunos Therapeutics, Inc. proceeds from contributed capital for the quarter ending 2012-12-31 was $0.00.
- Alaunos Therapeutics, Inc. proceeds from contributed capital for the quarter ending 2011-12-31 was $0.00.
- Alaunos Therapeutics, Inc. proceeds from contributed capital for fiscal 2013 was $0.00.
- Alaunos Therapeutics, Inc. proceeds from contributed capital for fiscal 2012 was $0.00.
- Alaunos Therapeutics, Inc. proceeds from contributed capital for fiscal 2011 was $0.00.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month | Proceeds from Contributed Capital 85 month | Proceeds from Contributed Capital 94 month | Proceeds from Contributed Capital 97 month | Proceeds from Contributed Capital 100 month | Proceeds from Contributed Capital 103 month | Proceeds from Contributed Capital 106 month | Proceeds from Contributed Capital 109 month | Proceeds from Contributed Capital 112 month | Proceeds from Contributed Capital 115 month | Proceeds from Contributed Capital 118 month | Proceeds from Contributed Capital 121 month | Proceeds from Contributed Capital 124 month | Proceeds from Contributed Capital 127 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $500.00K 10-Q · filed 2014-05-08 | |||||||||||||||
| 2013-12-31 | $0.00 10-K · filed 2014-03-03 | $500.00K 10-K · filed 2014-03-03 | ||||||||||||||
| 2013-09-30 | $500.00K 10-Q · filed 2013-10-22 | |||||||||||||||
| 2013-06-30 | $500.00K 10-Q · filed 2013-08-08 | |||||||||||||||
| 2013-03-31 | $500.00K 10-Q · filed 2013-05-07 | |||||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 10-K · filed 2014-03-03 | $500.00K 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | $500.00K 10-Q · filed 2012-11-08 | ||||||||||||||
| 2012-06-30 | $500.00K 10-Q/A · filed 2012-08-28 | |||||||||||||||
| 2012-03-31 | $500.00K 10-Q · filed 2012-05-03 | |||||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 10-K · filed 2014-03-03 | $500.00K 10-K · filed 2012-02-29 | |||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-08 | $500.00K 10-Q · filed 2011-11-03 | ||||||||||||||
| 2011-06-30 | $500.00K 10-Q/A · filed 2011-08-09 | |||||||||||||||
| 2010-09-30 | $500.00K 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |